Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marissa C van Maaren

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Oncoscience|January 21, 2017
Breast-conserving therapy versus mastectomyMarissa C van Maaren, Philip Poortmans, Sabine Siesling
Journal of Clinical Epidemiology|January 12, 2023
The majority of 922 prediction models supporting breast cancer decision-making are at high risk of biasTom A Hueting, Marissa C van Maaren, Mathijs P Hendriks, et al.
Breast (Edinburgh, Scotland)|April 23, 2023
External validation of 87 clinical prediction models supporting clinical decisions for breast cancer patientsTom A Hueting, Marissa C van Maaren, Mathijs P Hendriks, et al.
Scientific Reports|March 27, 2021
Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survivalArturo Moncada-Torres, Marissa C van Maaren, Mathijs P Hendriks, et al.
Statistics in Medicine|August 8, 2025
Doubly Robust Estimation of Marginal Cumulative Incidence Curves for Competing Risk AnalysisPatrick van Hage, Saskia le Cessie, Marissa C van Maaren, et al.
Lancet Regional Health. Americas|April 9, 2024
Which real indications remain for mastectomy?Maria Joao Cardoso, Jana de Boniface, David Dodwell, et al.
Cancer Epidemiology|February 8, 2022
Socioeconomic status and its relation with breast cancer recurrence and survival in young women in the NetherlandsMarissa C van Maaren, Bernard Rachet, Gabe S Sonke, et al.
Breast (Edinburgh, Scotland)|January 28, 2023
The use and misuse of risk prediction tools for clinical decision-makingMarissa C van Maaren, Tom A Hueting, Vinzenz Völkel, et al.
BMC Medical Research Methodology|June 10, 2019
Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the NetherlandsCornelia D van Steenbeek, Marissa C van Maaren, Sabine Siesling, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 2018
Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free yearsMarissa C van Maaren, Luc J A Strobbe, Marjolein L Smidt, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Oncoscience|January 21, 2017
Breast-conserving therapy versus mastectomyMarissa C van Maaren, Philip Poortmans, Sabine Siesling
Journal of Clinical Epidemiology|January 12, 2023
The majority of 922 prediction models supporting breast cancer decision-making are at high risk of biasTom A Hueting, Marissa C van Maaren, Mathijs P Hendriks, et al.
Breast (Edinburgh, Scotland)|April 23, 2023
External validation of 87 clinical prediction models supporting clinical decisions for breast cancer patientsTom A Hueting, Marissa C van Maaren, Mathijs P Hendriks, et al.
Scientific Reports|March 27, 2021
Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survivalArturo Moncada-Torres, Marissa C van Maaren, Mathijs P Hendriks, et al.
Statistics in Medicine|August 8, 2025
Doubly Robust Estimation of Marginal Cumulative Incidence Curves for Competing Risk AnalysisPatrick van Hage, Saskia le Cessie, Marissa C van Maaren, et al.
Lancet Regional Health. Americas|April 9, 2024
Which real indications remain for mastectomy?Maria Joao Cardoso, Jana de Boniface, David Dodwell, et al.
Cancer Epidemiology|February 8, 2022
Socioeconomic status and its relation with breast cancer recurrence and survival in young women in the NetherlandsMarissa C van Maaren, Bernard Rachet, Gabe S Sonke, et al.
Breast (Edinburgh, Scotland)|January 28, 2023
The use and misuse of risk prediction tools for clinical decision-makingMarissa C van Maaren, Tom A Hueting, Vinzenz Völkel, et al.
BMC Medical Research Methodology|June 10, 2019
Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the NetherlandsCornelia D van Steenbeek, Marissa C van Maaren, Sabine Siesling, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 2018
Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free yearsMarissa C van Maaren, Luc J A Strobbe, Marjolein L Smidt, et al.
Pageof 5